Literature DB >> 2384135

The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.

C Waeber1, L M Pinkus, J M Palacios.   

Abstract

The distribution of 5-HT3 receptor sites was examined in rat brain by autoradiography using 3H-enantiomers of zacopride. The (S)-3H-isomer labelled high densities of binding sites in the hippocampus, amygdala and cortex. The (R)-3H-isomer labelled considerably fewer sites than the (S)-isomer in nuclei of the lower medulla and did not exhibit any specific binding in the forebrain. These differences confirm that the (S)-isomer is specific for 5-HT3 binding sites and that it has a higher affinity than the (R)-isomer at these sites. These results are not consistent with the notion that 5-HT3 antagonist activity explains the anxiolytic effects of zacopride.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384135     DOI: 10.1016/0014-2999(90)90090-s

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning.

Authors:  G A Higgins; N Joharchi; P Nguyen; E M Sellers
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

Authors:  G A Higgins; B J Jones; N R Oakley; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala.

Authors:  F Mascagni; A J McDonald
Journal:  Neuroscience       Date:  2006-12-05       Impact factor: 3.590

4.  Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.

Authors:  M L López-Rodríguez; M J Morcillo; B Benhamú; M L Rosado
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

Review 5.  The central 5-HT3 receptor in CNS disorders.

Authors:  F E Bloom; M Morales
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

6.  Nervous system distribution of the serotonin 5-HT3 receptor mRNA.

Authors:  L H Tecott; A V Maricq; D Julius
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

Review 7.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment.

Authors:  Norbert Gyongyosi; Brigitta Balogh; Zita Katai; Eszter Molnar; Rudolf Laufer; Kornelia Tekes; Gyorgy Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2010-01-06       Impact factor: 3.575

9.  The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.

Authors:  D J Bill; J Coleman; I Hallett; V C Middlefell; K F Rhodes; A Fletcher
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon.

Authors:  M Morales; F E Bloom
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.